Clincosm LogoSign in Get a demo

Hepatitis C

Showing NaN - NaN of 58
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult-to-Adult Living Donor Liver Transplantation Study

Completed
  • Cirrhosis
  • +2 more
    • Los Angeles, California
    • +8 more
    Aug 27, 2017

    Hepatitis C, Cirrhosis, Portal Hypertension Trial in Worldwide (SOF, RBV)

    Completed
    Has Results
    • Hepatitis C
    • +3 more
    • Aurora, Colorado
    • +8 more
    Aug 5, 2016

    Hepatitis C, Hepatocellular Carcinoma Trial in New Zealand, Spain, United States (Sofosbuvir, Ribavirin)

    Completed
    Has Results
    • Hepatitis C
    • Hepatocellular Carcinoma
    • Los Angeles, California
    • +14 more
    Jun 16, 2016

    Hepatitis C Trial in Worldwide (Telaprevir, Peginterferon alfa-2b, Ribavirin)

    Terminated
    Has Results
    • Hepatitis C
    • Phoenix, Arizona
    • +23 more
    Jun 7, 2016

    Hepatitis C Trial in Worldwide (Daclatasvir, Telaprevir, Peginterferon alfa-2a)

    Completed
    Has Results
    • Hepatitis C
    • Birmingham, Alabama
    • +90 more
    Apr 28, 2016

    Hepatitis C Trial in Worldwide (TMC435, TVR)

    Completed
    Has Results
    • Hepatitis C
    • Bakersfield, California
    • +141 more
    Mar 24, 2016

    Hepatitis C Trial in Worldwide (TMC435)

    Completed
    • Hepatitis C
    • Bakersfield, California
    • +72 more
    Mar 31, 2016

    Hepatitis C Trial in Worldwide (DCV/ASV/BMS-791325)

    Completed
    • Hepatitis C
    • La Jolla, California
    • +65 more
    Oct 9, 2015

    Hepatitis C Trial in United States (Telaprevir, Ribavirin, Pegylated Interferon Alfa-2a)

    Terminated
    Has Results
    • Hepatitis C
    • Birmingham, Alabama
    • +26 more
    Jul 13, 2015

    Hepatitis C Trial in Canada, United States (Telaprevir, Ribavirin, Pegylated Interferon Alfa-2a)

    Terminated
    Has Results
    • Hepatitis C
    • Birmingham, Alabama
    • +21 more
    Jun 1, 2015

    Hepatitis C Trial in Worldwide (Telaprevir, Ribavirin, Pegylated Interferon Alfa-2a)

    Terminated
    Has Results
    • Hepatitis C
    • Birmingham, Alabama
    • +58 more
    Mar 3, 2015

    Hepatitis C, Human Immunodeficiency Virus Trial in Puerto Rico, United States (SOF, RBV)

    Completed
    Has Results
    • Hepatitis C
    • Human Immunodeficiency Virus
    • Birmingham, Alabama
    • +26 more
    Nov 14, 2014

    Hepatitis C Trial in Belgium, United States (ACH-0141625 (Sovaprevir), Placebo, Pegylated Interferon alpha-2a)

    Completed
    Has Results
    • Hepatitis C
    • ACH-0141625 (Sovaprevir)
    • +3 more
    • Los Angeles, California
    • +17 more
    Sep 8, 2014

    Hepatitis C Trial in Worldwide (biological, drug, other)

    Completed
    Has Results
    • Hepatitis C
    • Pegylated Interferon Alfa 2a
    • +3 more
    • Birmingham, Alabama
    • +115 more
    Jul 16, 2014

    Hepatitis C Trial in Anaheim, Philadelphia, Salt Lake City (Methadone, DCV 3DAA FDC, BMS-791325)

    Completed
    • Hepatitis C
    • Anaheim, California
    • +2 more
    Jun 16, 2014

    Hepatitis C Trial in Worldwide (Placebo, TMC435, Peginterferon alpha-2a (PegIFN alpha-2a))

    Completed
    Has Results
    • Hepatitis C
    • Placebo
    • +3 more
    • Dothan, Alabama
    • +62 more
    May 20, 2014

    Hepatitis C Trial in United States (Telaprevir, Peginterferon alfa-2a, Ribavirin)

    Withdrawn
    • Hepatitis C
    • Long Beach, California
    • +3 more
    May 13, 2014

    Hepatitis C, Thalassemia Trial in Canada, United Kingdom, United States (Peginterferon Alfa-2a and Ribavirin, Ribavirin)

    Completed
    • Hepatitis C
    • Thalassemia
    • Oakland, California
    • +4 more
    Mar 3, 2014

    Hepatitis, Hepatitis C Trial in Worldwide (Filibuvir, Placebo)

    Completed
    Has Results
    • Hepatitis
    • Hepatitis C
    • Anaheim, California
    • +76 more
    Dec 10, 2013

    Hepatitis C Trial in Puerto Rico, United States (Single Ascending Dose Cohorts GS-9620, Multiple Ascending Dose Cohorts GS-9620)

    Completed
    • Hepatitis C
    • Single Ascending Dose Cohorts GS-9620
    • Multiple Ascending Dose Cohorts GS-9620
    • Little Rock, Arkansas
    • +10 more
    Aug 12, 2013

    Hepatitis C Trial in United States (LADR Treatment)

    Completed
    Has Results
    • Hepatitis C
    • LADR Treatment
    • Los Angeles, California
    • +7 more
    Apr 11, 2013

    Hepatitis C Trial in Puerto Rico, United States (Peg-Intron, REBETOL, HCV 796)

    Completed
    • Hepatitis C
    • Anaheim, California
    • +34 more
    Feb 7, 2013

    Hepatitis C Virus Infection in HIV-Infected Children

    Completed
    • HIV Infections
    • Hepatitis C
      • Birmingham, Alabama
      • +38 more
      Oct 30, 2012

      Hepatitis C Trial in Puerto Rico, United States (GS-9669 tablets, Placebo to Match GS-9669 tablet)

      Completed
      • Hepatitis C
      • GS-9669 tablets
      • Placebo to Match GS-9669 tablet
      • Los Angeles, California
      • +10 more
      Jul 23, 2012

      Hepatitis C Trial in United States (CTS-1027, pegylated interferon, Ribavirin)

      Terminated
      Has Results
      • Hepatitis C
      • Birmingham, Alabama
      • +44 more
      Jun 4, 2012